Увійти

Готові списки джерел за темами / Prognosis factor / Книги

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Prognosis factor.

Книги з теми "Prognosis factor"

Автор: Grafiati

Опубліковано: 29 березня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 книг для дослідження на тему "Prognosis factor".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте книги для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Gospodarowicz, M. K., D. E. Henson, R. V. P. Hutter, B. O'Sullivan, L. H. Sobin, and Ch Wittekind, eds. Prognostic Factors in Cancer. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2003. http://dx.doi.org/10.1002/0471463736.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Hermanek, P., Mary K. Gospodarowicz, D. E. Henson, R. V. P. Hutter, and L. H. Sobin, eds. Prognostic Factors in Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-642-79395-0.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

K, Gospodarowicz M., and International Union against Cancer, eds. Prognostic factors in cancer. 2nd ed. New York: Wiley-Liss, 2001.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

K, Gospodarowicz M., O'Sullivan B, and Sobin L. H, eds. Prognostic factors in cancer. 3rd ed. Hoboken: Wiley, 2006.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

K, Gospodarowicz M., and International Union Against Cancer, eds. Prognostic factors in cancer. 2nd ed. New York: Wiley-Liss, 2001.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Paul, Hermanek, and International Union against Cancer, eds. Prognostic factors in cancer. Berlin: Springer, 1995.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Ulrik, Charlotte Suppli. Prognosis and risk factors for bronchial asthma. København: Lægeforeningens Forlag, 1998.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Hortobagyi, Gabriel N. Stage III breast cancer: Prognostic factors and therapy. Bethesda, MD (Bldg. 82, Rm. 103, Bethesda 20892): U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1988.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Th, Büchner, ed. Acute leukemias IV: Prognostic factors and treatment strategies. Berlin: Springer-Verlag, 1994.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

M, Thompson Alastair, ed. Prognostic and predictive factors in breast cancer. 2nd ed. London: Informa Healthcare, 2008.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Th, Büchner, ed. Acute leukemias: Prognostic factors and treatment strategies. Berlin: Springer-Verlag, 1987.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Grobbee, D. E. Clinical epidemiology: Principles, methods, and applications for clinical research. Sudbury, Mass: Jones and Bartlett Publishers, 2008.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Kataja, Vesa. Genital human papillomavirus (HPV) infections: Prevalence, incidence, risk factors and prognosis. Kuopio: University of Kuopio, 1992.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Waugh, Esther J. factors associated with short-term prognosis of conservatively treated lateral epicondylitis. Ottawa: National Library of Canada, 2002.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Abudu, Adesegun Tiburaniyu. Prognostic factors in primary Ewing's sarcoma of bone. Birmingham: University of Birmingham, 1997.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Th, Büchner, ed. Acute leukemias VI: Prognostic factors and treatment strategies. Berlin: Springer, 1997.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Th, Büchner, ed. Acute leukemias II: Prognostic factors and treatment strategies. Berlin: Springer-Verlag, 1990.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Pasqualina, Santaguida, United States. Agency for Healthcare Research and Quality., and McMaster University. Evidence-based Practice Center., eds. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. [Rockville, Md: Agency for Healthcare Research and Quality, 2005.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Gregorini, Paolo. Prognosi riservata: Stato dell'arte della sicurezza in sala operatoria. Milano: Il sole-24 ore, 2008.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Valentine, Andrea. Prognostic factors in transitional cell carcinoma of the bladder (TCCB). [S.l: The author], 2001.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Samuel, Kostrowicki Andrzej, Lityński Marek, Council for Mutual Economic Assistance., and Instytut Geografii i Przestrzennego Zagospodarowania (Polska Akademia Nauk), eds. Natural environment of suburban areas as a development factor of big cities: Papers from a scientific conference of the COMECON subject 1.3 "Evaluation and prognosis concerning the management of natural resources in the development of regions" Jabłonna, Poland, 28.04.-03.05. 1986 : papers from seminars and conferences. Warszawa: Institute of Geography and Spatial Organization, Polish Academy of Sciences, 1988.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Miettinen, Timo. Whiplash injuries in Finland: Incidence, prognosis and predictive factors for the long-term outcome. Kuopio: Kuopion yliopisto, 2005.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Harmsel, Willem Abraham ter. Studies on oncogenesis and prognostic factors in the premalignant and malignant uterine cervix. [Leiden: University of Leiden, 1998.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Wieselgren, Ing-Marie. Prognosis and Early Prognostic Factors in Schizophrenia. Almqvist & Wiksell Internat., 1995.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

25

WILLIAMS, Betty. Covid 19 Vacccine Guide: Comprehensive Guide on Corona Virus Vaccine, Signs and Symptoms, Host Factor, Causes, Transmission, Prognosis and Prevention. Independently Published, 2021.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Meyrier, Alain, and Patrick Niaudet. Primary focal segmental glomerulosclerosis. Edited by Neil Turner. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0057_update_001.

Повний текст джерела

Анотація:

Primary focal segmental glomerulosclerosis (FSGS) causes nephrotic syndrome and by definition is not caused by any of the known causes of podocyte toxicity or focal segmental sclerosis such as viral infections or toxins. A number of genetic causes of FSGS are commonly diagnosed in early childhood. Other causes of segmental scarring need to be distinguished. Genotypes in APOL1 of African origin are associated with higher incidence of FSGS and poorer responses to treatment. Cellular and collapsing FSGS are variants of FSGS in which there is overt acute podocytopathy and they have a relatively poor prognosis. A glomerular tip lesion is thought to have a slightly better prognosis than other types. Some cases of primary FSGS respond to high-dose corticosteroids, sometimes only after prolonged therapy. Response to steroids is a good prognostic sign, and without a response, progressive loss of renal function is likely. A circulating factor is implicated by the observation that proteinuria can recur in a donor kidney within hours of transplant. Plasma exchange appears to remove this factor but it is not conclusively identified.

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Martin, Albert K. Mesothelioma: Risk Factors, Treatment and Prognosis. Nova Science Publishers, Incorporated, 2021.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Martin, Albert K. Mesothelioma: Risk Factors, Treatment and Prognosis. Nova Science Publishers, Incorporated, 2021.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

29

Chawla, Jatinder, and Swapnil Gupta. Factors Affecting Prognosis or Complicating Treatment. Edited by Rajiv Radhakrishnan and Lily Arora. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190265557.003.0033.

Повний текст джерела

Анотація:

In this chapter factors affecting prognosis or complicating treatment will be reviewed including genetics, chronicity of illness, insight, adherence to treatment, physical health, primary support group, social environment, economics, access to care and the legal system

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Prognostic factors in cancer. 3rd ed. Hoboken, NJ: Wiley-Liss, 2006.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Gospodarowicz, Mary K., and Donald E. Henson. Prognostic Factors in Cancer. Island Press, 1995.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Hutter, Robert V. P., Paul Hermanek, Leslie H. Sobin, Donald E. Henson, and Mary K. Gospodarowicz. Prognostic Factors in Cancer. Springer London, Limited, 2012.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Graver, Benedict. Septic Shock: Risk Factors, Management and Prognosis. Nova Science Publishers, Incorporated, 2015.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Rodgers, Deanna. Myelodysplastic Syndromes: Risk Factors, Treatment and Prognosis. Nova Science Publishers, Incorporated, 2016.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Collier, Bethany R. Ovarian Cancer: Risk Factors, Therapies and Prognosis. Nova Science Publishers, Incorporated, 2015.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Guillory, Kevin, and Alex M. Carrasco. Huntington's Disease: Symptoms, Risk Factors and Prognosis. Nova Science Publishers, Incorporated, 2013.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Barrett, Chad L. Abdominal Injuries: Risk Factors, Management and Prognosis. Nova Science Publishers, Incorporated, 2015.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Ferrero, Simone. Endometrial Cancer: Risk Factors, Management and Prognosis. Nova Science Publishers, Incorporated, 2018.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Hansen, Donald C. Inguinal Hernia: Risk Factors, Prognosis and Management. Nova Science Publishers, Incorporated, 2015.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Naess, Halvor. Long-term prognosis. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198722366.003.0016.

Повний текст джерела

Анотація:

Knowledge of prognosis is important for patients in the prime of life in order to make informed decisions about treatment, choice of education, and profession. Median first-year mortality after first-ever cerebral infarction among young adults is about 4% while median annual average mortality after the first year is about 1.7%. Likewise, median first-year recurrence rate of cerebral infarction is 2% and thereafter 1.5% per year. Risk factors for recurrent cerebral infarction include hypertension, diabetes mellitus, symptomatic atherosclerosis, and smoking. Recurrent cerebral infarction and mortality are associated with increasing number of traditional risk factors. About 10% of patients develop post-stroke seizures within 6 years of the acute stroke. Almost 90% of patients report good functional outcome (modified Rankin Scale score ≤2) on long-term follow-up, but up to 30–50% of patients do not resume employment. Many patients have cognitive impairment. Fatigue and depression are also common on long-term follow-up.

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Kourti, Maria, and Emmanouel Hatzipantelis, eds. Prognostic Factors for Pediatric Tumors. MDPI, 2023. http://dx.doi.org/10.3390/books978-3-0365-9702-7.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Derricks, Sherri. Carotid Artery Disease: Risk Factors, Prognosis and Management. Nova Science Publishers, Incorporated, 2014.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Riley, Richard D., Danielle van der Windt, Peter Croft, and Karel G. M. Moons, eds. Prognosis Research in Health Care. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780198796619.001.0001.

Повний текст джерела

Анотація:

What is going to happen to me, doctor?’ ‘What outcomes am I likely to experience?’ ‘Will this treatment work for me?’ Prognosis—forecasting the future—has always been a part of medical practice and caring for the sick. In modern healthcare it now has a new importance, with large financial investments being made to personalize clinical decisions and tailor treatment strategies to improve individual health outcomes based on prognostic information. Prognosis research—the study of future outcomes in people with a particular health condition—provides the critical evidence for obtaining, evaluating, and implementing prognostic information within modern healthcare. This new book, written and edited by experts in the field, including clinicians, epidemiologists, statisticians, and other healthcare professionals, is a comprehensive and unified account of prognosis research in the broadest sense. It explains the concepts behind prognosis in medical practice and prognosis research, and provides a practical foundation for those developing, conducting, interpreting, synthesizing, and appraising prognosis studies. It recommends a framework of four basic prognosis research types, pioneered by the PROGRESS group, and provides explicit guidance on the conduct, analysis, and reporting of prognosis studies for each type. Key topics are overall prognosis in clinically relevant populations; prognostic factors associated with changes in prognosis across individuals; prognostic models for individual outcome risk prediction; and predictors of treatment effects. Examples are given of the impact of prognosis research across a broad range of healthcare topics, and the book also signals the latest developments in prognosis research, including systematic reviews and meta-analysis of prognosis studies, and the use of electronic health records and machine learning in prognosis research.

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Cassidy, Jim, Donald Bissett, Roy A. J. Spence OBE, Miranda Payne, Gareth Morris-Stiff, and Amen Sibtain. Colorectal cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199689842.003.0015_update_001.

Повний текст джерела

Анотація:

Breast cancer reviews the epidemiology and aetiology of this malignancy, with particular attention to the genetics underlying familial breast cancer, its pathology along with its receptors, oestrogen receptor (ER), the growth factor receptor HER2, and epidermal growth factor receptor (EGFR), and the bearing these have on treatment and prognosis. The benefits of breast cancer screening in the population and families at higher risk are discussed. Presenting symptoms and signs are followed by investigation including examination, bilateral mammography, and core biopsy of suspicious lesions. Management of non-invasive in situ disease is considered. Invasive breast cancer is staged according to TNM guidelines. Early breast cancer is defined, managed frequently by breast conserving surgery and sentinel node biopsy from the axilla. A positive sentinel node biopsy requires clearance of the axilla. Larger lesions may require mastectomy. Breast radiotherapy is indicated after breast conserving surgery. Following surgery, the risk of systemic micrometastatic disease is estimated from the primary size, lymph node spread, and tumour grade. Adjuvant chemotherapy improves treatment outcome in all but very good prognosis premenopausal breast cancer, and intermediate or poor prognosis postmenopausal breast cancer. This is combined with trastuzumab in HER2 positive disease. Adjuvant endocrine therapy is recommended for all ER positive breast cancer, tamoxifen in premenopausal, aromatase inhibitors in postmenopausal women. Neoadjuvant chemotherapy may be used in large operable breast cancers to facilitate breast conserving surgery. Locally advanced breast cancer is defined, its high risk of metastatic disease requiring full staging before treatment. Systemic therapy is often best first treatment, according to receptor profile. Metastatic breast cancer although incurable can be controlled for years using endocrine therapy, chemotherapy, trastuzumab, palliative radiotherapy, and bisphosphonates as appropriate. Male breast cancer is uncommon, but management similar.

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Orth, Stephan R. Smoking in chronic kidney disease. Edited by David J. Goldsmith. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0103.

Повний текст джерела

Анотація:

Smoking has been acknowledged as the number one preventable cause of death in most countries. The adverse effects of smoking on the kidney are less known. Prospective, population-based, observational studies, and evidence from experimental work indicate that smoking (a) is a relevant risk factor for chronic kidney disease (CKD) in the general population and (b) is associated with an increased risk of deterioration in renal function in CKD patients. The latter is especially true for patients with diabetic nephropathy or hypertensive renal damage. The conclusion is that smoking is an important renal risk factor and nephrologists should make greater efforts to motivate patients to stop smoking, not least because smoking cessation improves the prognosis of CKD.

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Coleman, Denise S. Progressive Multifocal Leukoencephalopathy: Risk Factors, Management Strategies and Prognosis. Nova Science Publishers, Incorporated, 2015.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Prognostic Factors in Cancer, 2nd Edition. 2nd ed. Wiley-Liss, 2001.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

48

Pneumothorax: Classification, Treatment and Prognostic Factors. Nova Science Pub Inc, 2013.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Screening of tMTHFR, Factor V Leiden and hyperhomocyst(e)inemia: Emerging prognostic factors in myocardial infarction? Ottawa: National Library of Canada, 1999.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

50

Desai, Anjali, and Andrew S. Epstein. Doctors’ Prognostic Accuracy in Terminally Ill Patients (DRAFT). Edited by Nathan A. Gray and Thomas W. LeBlanc. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190658618.003.0031.

Повний текст джерела

Анотація:

“Doctors’ Prognostic Accuracy in Terminally Ill Patients” reviews one of Christakis and Lamont’s landmark articles, which investigated the factors associated with prognostic accuracy (and prognostic error) in doctors’ prognoses for terminally ill patients. The article explored the extent and determinants of optimistic errors, pessimistic errors, and correct predictions among doctors who were estimating prognoses for their terminally ill patients. This chapter offers a concise breakdown of the study’s design and salient study results while also pointing out study limitations. The chapter summarizes other relevant studies exploring prognostic estimates and prognostic disclosure by physicians to terminally ill cancer patients. Finally, the chapter provides a clinical case to illustrate some of the study’s practical implications for patient care.

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!